Sign in
Taking people in United StatesNo phase

Comparing two ways of sampling the esophagus in people with Barrett's esophagus

Compares Seattle biopsies with WATS3D brushings in people with known or suspected Barrett's esophagus.

Key facts

Who runs it
University of Colorado, Denver
Where
Aurora, Bristol, Chapel Hill, Chicago, Danville, Gilbert, Knoxville, Los Angeles, New Hyde Park, New York, Oakland, Rochester, and Sarasota, United StatesSee the 14 sites
Trial code
Registry title
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Status
Recruiting
People taking part
2,298 people, planned
Started
3 Oct 2022
Planned end
Jun 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Seattle protocol
  • WATS3D brushings
Record updated
1 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults having an endoscopy (a camera tube down the throat) to check for or follow up Barrett's esophagus. It compares two ways of taking samples: Seattle biopsy protocol and WATS3D brushings.

Age
18-89 years
Sex
All sexes
Disease stage
Follow-up group: Barrett's esophagus without precancerous changes (non-dysplastic) at the last endoscopy. People who once had low-grade or unclear (indefinite) dysplasia can join if the last endoscopy showed none. Screening group: people having an endoscopy to look for Barrett's esophagus. In both groups, Barrett's length of at least M1. Life expectancy of at least 2 years.
Earlier treatment
Follow-up group cannot have had endoscopic eradication therapy (EET) before. No one can have had earlier esophagus or stomach surgery, except uncomplicated fundoplication.

Main reasons for not taking part

  • Being checked or evaluated for EET because of earlier Barrett's-related dysplasia or esophageal adenocarcinoma
  • Active inflamed, eroded esophagus (erosive esophagitis) of LA Grade B or higher
  • Swollen veins in the esophagus (esophageal varices)
  • Earlier esophagus or stomach surgery, except uncomplicated fundoplication
  • Pregnancy

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Surveillance Population
  • Undergoing surveillance endoscopy for a diagnosis of non-dysplastic Barrett's esophagus (NDBE, based on last endoscopic procedure; patients with prior history of low-grade dysplasia/indefinite for dysplasia with NDBE at last endoscopy can be included)
  • Barrett's esophagus (BE) length of at least M1
  • English and Spanish speaking
  • Able to comprehend and complete the consent form
  • Age18-89 years
  • Life-expectancy of at least 2 years; Screening Population
  • Undergoing endoscopy for screening of BE
  • BE length of at least M1
  • English and Spanish speaking
  • Able to comprehend and complete the consent form
  • Age 18-89 years
  • Expected life-expectancy of at least 2 years; Physicians; -All participating sites will include physicians who are trained in the use of WATS3D and certified by the site PI. All endoscopists will need to complete a minimum of three cases to be eligible to participate in the study

Who cannot take part

  • BE patients undergoing surveillance or evaluation for endoscopic eradication therapy (EET) for prior diagnosis of BE related dysplasia or esophageal adenocarcinoma (EAC)
  • Prior history of EET
  • Prior history of esophageal or gastric surgery, except for uncomplicated fundoplication
  • BE patients undergoing surveillance or evaluation for EET for prior diagnosis for BE-related dysplasia or EAC
  • Prior history of esophageal or gastric surgery, except for uncomplicated fundoplication
  • Surveillance Population
  • Active erosive esophagitis with LA Grade B or higher
  • Esophageal varices
  • Pregnancy; Screening Population
  • Active erosive esophagitis with LA Grade B or higher
  • Esophageal varices
  • Pregnancy

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 89 years old?

Where in United States

  • University of Colorado Anschutz Medical CampusAurora, United StatesContact: Alexa DeBord, MSTaking people
  • Connecticut Clinical Research InstituteBristol, United StatesContact: Salam Zakko, MDTaking people
  • University of North Carolina at Chapel HillChapel Hill, United StatesContact: Nicholas Shaheen, MDTaking people
  • Northwestern UniversityChicago, United StatesContact: Srinadh Komanduri, MDTaking people
  • Geisinger Medical CenterDanville, United StatesContact: Harshit Khara, MDTaking people
  • Arizona Centers of Digestive HealthGilbert, United StatesContact: Mankanwal Sachdev, MDTaking people
  • Gastrointestinal Associates, PCKnoxville, United StatesContact: Kathy Karnes, BSN, RNTaking people
  • UCLA / Jonsson Comprehensive Cancer CenterLos Angeles, United StatesContact: Raman Muthusamy, MDTaking people
  • Long Island Jewish Medical CenterNew Hyde Park, United StatesContact: Molly Stewart, BSTaking people
  • Weill Cornell MedicineNew York, United StatesContact: Felice Schnoll-Sussman, MDTaking people
  • Kaiser PermanenteOakland, United StatesContact: Howard Chang, MDTaking people
  • Mayo ClinicRochester, United StatesContact: Prasad Iyer, MDTaking people
  • University of RochesterRochester, United StatesContact: Vivek Kaul, MDTaking people
  • Suncoast Endoscopy of SarasotaSarasota, United StatesContact: Scott Corbett, MDTaking people

About the trial

What the trial wants to find out

The purpose of this research study is to learn about the best approach to sample patients with known or suspected Barrett's esophagus (BE) by comparing the standard Seattle biopsy protocol to sampling using wide area transepithelial sampling (WATS3D).

Read full original descriptionShow less

Barrett's esophagus is a common condition that is used to spot patients at increased risk of developing a type of cancer in the esophagus (swallowing tube) called esophageal adenocarcinoma. The 5-year survival rate is as low as 18% for patients who get esophageal adenocarcinoma, but the rate may be improved if the cancer is caught in its early stages. Barrett's esophagus can lead to dysplasia, or precancerous changes, which occurs when cells look abnormal but have not developed into cancer. If the abnormal cells increase from being slightly abnormal (low-grade dysplasia), to being very abnormal (high-grade dysplasia), the risk of developing cancer (esophageal adenocarcinoma) goes up. Therefore, catching dysplasia early is very important to prevent cancer.

Endoscopic surveillance is a type of procedure where endoscopists run a tube with a light and a camera on the end of it down a patients throat and remove a small piece of tissue. The piece of tissue, called a biopsy, is about the size of the tip of a ball-point pen and is checked for abnormal cells and cancer cells.

Patients are being asked to be in this research study because they have been diagnosed with BE or suspected to have BE, and will need an esophagogastroduodenoscopy (EGD).

Patients with BE undergo sampling using the Seattle biopsy protocol during which samples are obtained from the BE in a four quadrant fashion every 2 cm along with target biopsies from any abnormal areas within the BE. Another sampling approach is WATS3D which utilizes brushings from the BE.

While both of these procedures are widely accepted approaches to sampling patients with BE during endoscopy, there is not enough research to show if one is better than the other.

Participants in this study will undergo sampling of the BE using both approaches (Seattle biopsy protocol and WATS-3D); the order of the techniques will be randomized.

Up to 2700 participants will take part in this research. This is a multicenter study involving several academic, community and private hospitals around the country.

The 2 groups in the trial

  • Seattle protocol, then WATS3D brushings.Other group

    Participants in the screening or surveillance population that receive the Seattle protocol, then WATS3D brushings, during the same procedure.

    Treatment: Seattle protocol and WATS3D brushings

  • WATS3D brushings, then Seattle Protocol.Other group

    Participants in the screening or surveillance population that receive the WATS3D brushings, then the Seattle protocol, during the same procedure.

    Treatment: Seattle protocol and WATS3D brushings

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter Randomized Trial of Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance (The SWAT-BE Study)
Plain-language title
Comparing two ways of sampling the esophagus in people with Barrett's esophagusGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT05530343, who can take part
Record updated
1 July 2026